Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Activating the Nrf2 pathway reduces inflammation and cell activation in human hair follicles, suggesting a potential treatment for certain hair loss conditions.

Interferon α‐2b can temporarily reduce hepatitis C virus and normalize liver enzyme levels.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Ginseng extracts protect brain cells and reduce damage in diabetic rats.

Autologous growth factor concentrate therapy shows promise for treating early-stage hair loss safely and effectively.

A new treatment using probiotic microneedles shows promise for promoting hair growth and reducing inflammation in androgenetic alopecia.

FGF-2&D/P nanoparticles can help treat hair loss.

CGF-PF may improve hair loss treatment by targeting hair follicle stem cells more effectively.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Anti-EGF serum affects growth and development in newborn mice.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

Scientists created tiny particles loaded with a hair growth drug, minoxidil, that specifically target hair follicles and skin cells to potentially improve hair growth.

Gamma/delta T cells help defend skin against heavy metals.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

HGF-modified hair follicle stem cells help brain recovery after injury in rats.

The new microneedle system promotes hair growth by improving the hair follicle environment.

Methylated flavonoids may effectively reduce depression and inflammation caused by finasteride.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

PRGF can improve acne and scars.

New nanocarriers were developed for safer, targeted drug delivery and diagnostics, showing promise for future medical use.

ANA-negative lupus nephritis can be diagnosed and treated effectively with a comprehensive approach.